TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07258407: A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Sponsor: T.O.A.D. Oncology SA · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 180 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT07258407 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07258407 Rescue Dossier →